NCCN Guidelines Insights: Colon Cancer, Version 2.2018.

Journal Article (Journal Article)

The NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, perioperative treatment, surveillance, management of recurrent and metastatic disease, and survivorship. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel discussions for the 2018 update of the guidelines regarding risk stratification and adjuvant treatment for patients with stage III colon cancer, and treatment of BRAF V600E mutation-positive metastatic colorectal cancer with regimens containing vemurafenib.

Full Text

Duke Authors

Cited Authors

  • Benson, AB; Venook, AP; Al-Hawary, MM; Cederquist, L; Chen, Y-J; Ciombor, KK; Cohen, S; Cooper, HS; Deming, D; Engstrom, PF; Garrido-Laguna, I; Grem, JL; Grothey, A; Hochster, HS; Hoffe, S; Hunt, S; Kamel, A; Kirilcuk, N; Krishnamurthi, S; Messersmith, WA; Meyerhardt, J; Miller, ED; Mulcahy, MF; Murphy, JD; Nurkin, S; Saltz, L; Sharma, S; Shibata, D; Skibber, JM; Sofocleous, CT; Stoffel, EM; Stotsky-Himelfarb, E; Willett, CG; Wuthrick, E; Gregory, KM; Freedman-Cass, DA

Published Date

  • April 2018

Published In

Volume / Issue

  • 16 / 4

Start / End Page

  • 359 - 369

PubMed ID

  • 29632055

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2018.0021


  • eng

Conference Location

  • United States